Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Not applicableLooking for participantsNCT04512144
What this trial is testing

Mindfulness in Endometrial and Cervical Cancer

Who this might be right for
Gynecologic CancerEndometrial CancerCervical Cancer+2 more
St. Louis University 120
Not applicableLooking for participantsNCT07270666
What this trial is testing

CtDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714070
What this trial is testing

Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia

Who this might be right for
Endometrial NeoplasmsEndometrial CancerAtypical Endometrial Hyperplasia+1 more
Peking University People's Hospital 48
Not applicableStudy completedNCT03466788
What this trial is testing

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

Who this might be right for
Endometrial CancerChemotherapy EffectQuality of Life
Centre Francois Baclesse 51
Early research (Phase 1)Study completedNCT03508570
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

Who this might be right for
Malignant Peritoneal NeoplasmMalignant Retroperitoneal NeoplasmMetastatic Cervical Carcinoma+31 more
M.D. Anderson Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT00005583
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634601
What this trial is testing

Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)WithdrawnNCT04197219
What this trial is testing

Pembrolizumab With Axitinib in Recurrent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Cancer
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003267
What this trial is testing

Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer

Who this might be right for
Cervical CancerEndometrial CancerInfection+2 more
European Organisation for Research and Treatment of Cancer - EORTC 214
Not applicableLooking for participantsNCT07622901
What this trial is testing

Fasting InTervention for Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Miami 42
Not applicableStudy completedNCT04972682
What this trial is testing

[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial NeoplasmsEndometrial Adenocarcinoma+6 more
Moscow City Oncology Hospital No. 62 102
Not applicableNot Yet RecruitingNCT06900582
What this trial is testing

SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial

Who this might be right for
LymphadenectomyEndometrial CancerGene, p53+1 more
University Hospital, Strasbourg, France 374
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Early research (Phase 1)Ended earlyNCT06457997
What this trial is testing

PHN-010 in Patients With Advanced Solid Tumors

Who this might be right for
Lung CancerColon CancerEndometrial Cancer+4 more
Pheon Therapeutics 26
Testing effectiveness (Phase 2)Ended earlyNCT05325866
What this trial is testing

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Solid Tumors
Amgen 260
Not applicableUnknownNCT00501761
What this trial is testing

Physical Activity After Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 326
Not applicableNot Yet RecruitingNCT07006103
What this trial is testing

Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification

Who this might be right for
Endometrial Cancer, Endometrial Neoplasm
Hospital Italiano de Buenos Aires 400
Not applicableUnknownNCT01119573
What this trial is testing

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 100
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Next Page